Literature DB >> 8246635

Evidence for accelerated skin wrinkling among developmentally delayed individuals with Down's syndrome.

K L Brugge1, G L Grove, P Clopton, M J Grove, D J Piacquadio.   

Abstract

Down's Syndrome (DS) is a genetic disorder involving mental retardation which is reported to be a condition of accelerated aging. However, few studies exist which examine age-dependent changes in DS and these studies fail to include a control group. In the present study a non-invasive, painless, and easily obtainable measure reflecting age-dependent topographical changes of the skin (skin wrinkling) was obtained in 15 DS subjects, 14 developmentally disabled (DD) (mentally retarded) controls (DD controls) and 16 healthy controls of similar ages ranging from 22 to 51 years. The healthy control group failed to show correlations of skin measures with age, as predicted for the age-range of these subjects, based on results of previous studies. However, the DS group showed significant correlations of all skin measures from relatively non-sun-exposed and sun-exposed skin sites, with age. The DD control also showed significant correlations with age of several but not all skin sites and the correlation coefficients tended to be less than that of the DS; at least, when contrasted with the healthy controls the DS showed greater values of several skin measures suggestive of accelerated skin wrinkling. These results provide evidence for accelerated aging of the skin, and possibly greater effects of sun-exposure on skin wrinkling, in DS and possibly (DD) individuals in contrast to healthy individuals without a genetic disorder and without mental retardation.

Entities:  

Mesh:

Year:  1993        PMID: 8246635     DOI: 10.1016/0047-6374(93)90049-w

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  4 in total

1.  Health conditions associated with aging and end of life of adults with Down syndrome.

Authors:  Anna J Esbensen
Journal:  Int Rev Res Ment Retard       Date:  2010

2.  Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome.

Authors:  A Contestabile; T Fila; A Cappellini; R Bartesaghi; E Ciani
Journal:  Cell Prolif       Date:  2009-04       Impact factor: 6.831

3.  Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21.

Authors:  Chi-Ming Li; Meirong Guo; Martha Salas; Nicole Schupf; Wayne Silverman; Warren B Zigman; Sameera Husain; Dorothy Warburton; Harshwardhan Thaker; Benjamin Tycko
Journal:  BMC Med Genet       Date:  2006-03-15       Impact factor: 2.103

4.  Low risk of solid tumors in persons with Down syndrome.

Authors:  Henrik Hasle; Jan M Friedman; Jørgen H Olsen; Sonja A Rasmussen
Journal:  Genet Med       Date:  2016-03-31       Impact factor: 8.822

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.